# Ralph Baric (1954)

> Pioneer ricerca coronavirus, creatore virus chimerici, architetto remdesivir e vaccini mRNA, al centro della controversia lab leak

## Dati Essenziali

| Aspetto | Dettaglio |
|---------|-----------|
| **Nascita** | 1954, New Jersey, USA |
| **Nazionalita** | USA |
| **Residenza** | Haw River, North Carolina |
| **Sport** | Ex-nuotatore NCAA, campione ACC (NC State) |

**Nota biografica:** Arrivo' a NC State con borsa atletica per nuoto, dove vinse campionati ACC e stabili' record in 500yd, 1000yd, 1650yd Freestyle e 400yd Individual Medley. Rimase per il PhD e divenne uno dei massimi esperti mondiali di coronavirus.

---

## Formazione

| Periodo | Istituzione | Dettaglio |
|---------|-------------|-----------|
| **1973-1977** | [NC State University](../university/nc-state.md) | BSc Zoology (borsa atletica nuoto) |
| **1977-1983** | NC State University | PhD Microbiology |
| **1982-1986** | [University of Southern California](../university/usc.md) | Postdoctoral Fellow, Virology |

---

## Carriera e Ruoli

### Timeline Professionale

| Periodo | Ruolo | Organizzazione |
|---------|-------|----------------|
| **1986-oggi** | Professor → Distinguished Professor | [UNC Chapel Hill](../university/unc.md) |
| **oggi** | William R. Kenan Jr. Distinguished Professor | Dept. Epidemiology, UNC |
| **oggi** | Professor | Dept. Microbiology and Immunology, UNC |
| **2021** | Elected Member | [National Academy of Sciences](../agency/national-academy-sciences.md) |
| **2022** | Elected Member | [American Academy of Arts and Sciences](../forum/american-academy-arts-sciences.md) |

### Finanziamenti Principali

| Anno | Grant | Importo |
|------|-------|---------|
| **2012** | NIH virus infection treatments | $21.4M |
| **2013** | NIH continued research | $10M |
| **2017** | NIH coronavirus therapy | $6M |
| **2020s** | NIAID AViDD Center | $65M |
| **Totale carriera** | NIH grants | $100M+ |

### Brevetto Fondamentale

**US Patent 7,279,327** (filed 19 aprile 2002): "Methods for producing recombinant coronavirus". Inventori: Kristopher M. Curtis, Ralph S. Baric, Boyd Yount. Assegnato a UNC Chapel Hill. Brevetto fondativo per la genetica inversa dei coronavirus.

### Contributi Scientifici Chiave

| Anno | Contributo |
|------|------------|
| **1990s** | Sviluppo tecniche genetica inversa per coronavirus (MHV, TGEV) |
| **2002** | Brevetto US 7,279,327 - metodi per coronavirus ricombinanti |
| **2003** | Clone cDNA full-length infettivo di SARS-CoV (PNAS) - in ~2 mesi da RNA virale |
| **2013** | Clone cDNA full-length infettivo di MERS-CoV (PNAS) |
| **2015** | Paper Nature Medicine: virus chimerico SHC014-MA15 con Shi Zhengli |
| **2016-2017** | Identificazione remdesivir come antivirale pan-coronavirus |
| **2018-2019** | Collaborazione NIH/VRC per vaccino mRNA anti-MERS |
| **2020** | Tra i primi a ricevere e analizzare SARS-CoV-2 |
| **2020** | Contributo a sviluppo vaccino Moderna |
| **2020** | Nomenclatura ufficiale SARS-CoV-2 |
| **2024** | Sviluppo vaccino pan-coronavirus mRNA (12 spike proteins) |

---

## Contributi a Farmaci e Vaccini COVID-19

### Remdesivir (Gilead Sciences)

| Aspetto | Dettaglio |
|---------|-----------|
| **Timeline** | Identificato 2016-2017, pubblicato 2017 |
| **Scoperta** | Primo antivirale broad-spectrum contro tutti i coronavirus conosciuti |
| **FDA Approval** | Emergency Use Authorization maggio 2020 |
| **Impatto** | Primo farmaco anti-COVID-19 approvato al mondo |

### Molnupiravir (EIDD-2801)

| Aspetto | Dettaglio |
|---------|-----------|
| **Scoperta** | Emory Institute for Drug Development (EIDD) / DRIVE |
| **Preclinica** | Baric lab (UNC) + Mark Denison (Vanderbilt) dimostrarono efficacia vs SARS-CoV-2 |
| **Licenza** | [Ridgeback Biotherapeutics](../pharma/ridgeback-biotherapeutics.md) (Wayne Holman, Wendy Painter) |
| **Sviluppo globale** | Partnership Ridgeback-[Merck](../pharma/merck.md) |
| **Vantaggio** | Orale (pillola) vs remdesivir (IV) |
| **Ruolo Baric** | Co-autore risultati Phase 2a trial con Ridgeback |

### Vaccini mRNA (Moderna/NIH)

| Aspetto | Dettaglio |
|---------|-----------|
| **Collaborazione** | NIH Vaccine Research Center, 2018-2019 |
| **Focus iniziale** | Vaccino mRNA anti-MERS-CoV |
| **Pivot COVID** | Expertise trasferita rapidamente a SARS-CoV-2 |
| **Risultato** | Framework scientifico per vaccino Moderna |

> "Con questi vaccini mRNA, non c'e' stata perdita di funzione" negli anziani e immunocompromessi.
> — Baric sui risultati dei trial

### Vaccino Pan-Coronavirus (2024)

Baric sta sviluppando vaccino mRNA che combina spike proteins di 12 coronavirus diversi, inclusi SARS, SARS-2 e varianti correlate.

---

## Il Paper del 2015 e la Controversia

### Nature Medicine 2015

**Titolo:** "A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"

**Co-autori chiave:** Vineet Menachery, [Shi Zhengli](shi-zhengli.md), Ralph Baric

**Cosa fecero:**
- Crearono virus chimerico: spike di coronavirus pipistrello (SHC014) + backbone di SARS adattato ai topi
- Dimostrarono che il virus poteva replicarsi in cellule respiratorie umane
- Finanziato da NIH

**Controversia:**
- Definito da alcuni gain-of-function research
- Contribui' al moratorium 2017 dell'amministrazione Obama
- Durante COVID-19, citato come esempio di ricerca rischiosa

### Posizione di Baric

> "We never provided the chimeric virus sequence, clones, or viruses to researchers at the WIV; and Dr. Shi, or members of her research team, never worked in our laboratory at UNC."

> "Anyone saying there was no justification to do the work in 2015 is simply not acknowledging the infrastructure that contributed to therapeutics and vaccines for covid-19."

> "We never created a supervirus. That's a figment of his (Rand Paul's) imagination and obviously being used for political advancement."

### Project DEFUSE (2018)

Proposta DARPA respinta:
- **PI:** Peter Daszak (EcoHealth Alliance)
- **Co-investigatori:** Shi Zhengli, Linfa Wang, Ralph Baric
- **Obiettivo:** Inserimento siti clivaggio furina in coronavirus pipistrelli
- **Esito:** Mai finanziata

**Commento di Baric sulla proposta:**
> "In the U.S., these recombinant SARS coronaviruses are studied under BSL-3, not BSL-2. In China, might be growing these viruses under BSL-2. U.S. researchers will likely freak out."

---

## Inchieste Congressuali (2024-2025)

### House Select Subcommittee on the Coronavirus Pandemic

| Data | Evento |
|------|--------|
| **Aprile 2024** | Deposizione sotto giuramento |
| **Contenuto** | 8+ ore di testimonianza transcritta |

**Punti chiave dalla testimonianza:**
- Ammise che origine zoonotica e' "most likely" ma lab leak e' "possible"
- Difese gain-of-function research come necessaria per sviluppo farmaci
- Nego' di aver creato "superviruses"
- Confermo' preoccupazioni su standard BSL-2 in Cina

### Robert Redfield Claims (Novembre 2024)

Ex CDC Director Robert Redfield ha dichiarato in un'intervista podcast di credere che SARS-CoV-2 sia stato sviluppato nell'ambito di un "biodefense program" a UNC Chapel Hill e ha definito Baric il "scientific mastermind". Redfield ha ammesso di non avere prove definitive.

### North Carolina State Investigation (2025)

| Data | Evento |
|------|--------|
| **Giugno 2025** | Speaker Destin Hall richiede documenti a UNC |
| **Scope** | Records dal 2 luglio 2020 al 12 agosto 2024 |
| **Focus** | Baric Lab, SARS-CoV-2, Wuhan Institute of Virology |

### Causa FOIA contro UNC (2025-2026)

Un nonprofit (US Right to Know) ha fatto causa a UNC per il rifiuto di rilasciare documenti di ricerca relativi a Baric e le origini COVID-19. A gennaio 2026, la NC Court of Appeals ha confermato il diritto di UNC a trattenere migliaia di pagine di documenti sulla genetic engineering research.

### DNI Investigation

**Maggio 2025:** Director of National Intelligence Tulsi Gabbard annuncia nuova indagine sulle origini COVID-19.

### Minacce Legislative

| Anno | Proposta |
|------|----------|
| **2025** | Bills per vietare gain-of-function research |
| **2025** | Proposta ban collaborazioni con "countries of concern" |
| **2025** | Amministrazione Trump cerca tagli fondi NIH |

---

## READDI-AViDD Center

| Aspetto | Dettaglio |
|---------|-----------|
| **Nome** | Rapidly Emerging Antiviral Drug Development Initiative |
| **Grant** | $65M da NIAID (maggio 2022) |
| **Program Director** | Ralph Baric |
| **Co-director** | Tim Willson (UNC Eshelman School of Pharmacy) |
| **Co-founders** | Mark Heise, Nathaniel Moorman |
| **Partner corporate** | Janssen (J&J), Takeda, Chimerix, Pardes Biosciences |
| **Consorzio** | 20+ istituzioni in 5 nazioni (Toronto, Duke, Vanderbilt) |
| **Target** | Coronavirus, flavivirus, alphavirus, filovirus |

Uno dei 9 AViDD Centers del NIH Antiviral Program for Pandemics (APP).

---

## Intelligence e Governo USA

| Data | Evento |
|------|--------|
| **~2015-2020** | Advisor ODNI su biological threats (~4 volte/anno) |
| **Settembre 2015** | ODNI facilita incontro CIA-Baric su "coronavirus evolution and possible natural human adaptation" |
| **Gennaio 2020** | Presenta a ODNI ipotesi che COVID possa avere origine da laboratorio |
| **Gennaio 2021** | Biological threats hub ODNI scarta evidenze lab leak come "misinformation" |

Documenti rilasciati dal Sen. Rand Paul, ottobre 2025.

---

## Onorificenze

| Anno | Riconoscimento |
|------|----------------|
| **1986** | Harvey Weaver Scholar, National Multiple Sclerosis Society |
| **1994** | Established Investigator Award, American Heart Association |
| **2019** | William R. Kenan Jr. Distinguished Professorship |
| **2021** | O. Max Gardner Award (massimo onore UNC System) |
| **2021** | Elected Member, National Academy of Sciences |
| **2022** | Elected Member, American Academy of Arts and Sciences |
| **2017-2025** | Clarivate Highly Cited Researchers (multiple years) |

**Pubblicazioni:** >200 paper. >127,500 citazioni (Google Scholar).

---

## Rete di Connessioni

### Mappa delle Appartenenze

```
                    RALPH BARIC
                         |
      +------------------+------------------+
      |                  |                  |
      v                  v                  v
    UNC              NIH/NIAID          Pharma
  Chapel Hill        Grants            Partners
  (1986-)           ($100M+)              |
  Distinguished                           |
  Professor                    +----------+----------+
      |                        |          |          |
      v                        v          v          v
 Collaborators              Gilead    Moderna    Merck
      |                   remdesivir  mRNA vax  molnupiravir
      |
      +------------------+------------------+
      |                  |                  |
      v                  v                  v
 Shi Zhengli       Peter Daszak       Linfa Wang
 (2015 paper)      (EcoHealth)        (DEFUSE)
```

### Network Professionale

| Nome | Connessione |
|------|-------------|
| [Shi Zhengli](shi-zhengli.md) | Co-autore paper 2015, collaborazione ricerca WIV |
| [Peter Daszak](peter-daszak.md) | PI EcoHealth Alliance, Co-PI Project DEFUSE |
| [Linfa Wang](linfa-wang.md) | Co-investigator Project DEFUSE |
| [Anthony Fauci](anthony-fauci.md) | Director NIAID, supervisore grants NIH |
| Mark Denison | Vanderbilt, 17+ anni collaborazione, co-sviluppo molnupiravir |
| Timothy Sheahan | UNC, PhD student dal 2003, ora Gillings Asst Professor |
| Vineet Menachery | Primo autore paper 2015, collaboratore UNC |
| Boyd Yount | UNC, co-inventore brevetto US 7,279,327 |
| Tim Willson | Co-director READDI-AViDD Center |

---

## Connessioni PowerLink

### Organizzazioni

| Entita | Connessione |
|--------|-------------|
| [UNC Chapel Hill](../university/unc.md) | Distinguished Professor 1986- |
| [NC State University](../university/nc-state.md) | Alumni BSc 1977, PhD 1983 |
| [USC](../university/usc.md) | Postdoc 1982-1986 |
| [NIAID](../agency/niaid.md) | Major grant recipient ($100M+) |
| [National Academy of Sciences](../agency/national-academy-sciences.md) | Member 2021 |
| [EcoHealth Alliance](../foundation/ecohealth-alliance.md) | Collaborator, Co-PI DEFUSE |
| [Gilead Sciences](../company/gilead.md) | Partner remdesivir |
| [Moderna](../pharma/moderna.md) | Partner mRNA vaccines |
| [Merck](../pharma/merck.md) | Partner molnupiravir (via Ridgeback) |
| [Ridgeback Biotherapeutics](../pharma/ridgeback-biotherapeutics.md) | Partner molnupiravir preclinical |
| [American Academy of Arts and Sciences](../forum/american-academy-arts-sciences.md) | Member 2022 |
| [Governo USA](../government/governo-usa.md) | ODNI/CIA advisor biodefense |

### Persone

| Persona | Relazione |
|---------|-----------|
| [Shi Zhengli](shi-zhengli.md) | Collaboratrice ricerca coronavirus |
| [Peter Daszak](peter-daszak.md) | Co-investigator DEFUSE, EcoHealth |
| [Linfa Wang](linfa-wang.md) | Co-investigator DEFUSE |
| [Anthony Fauci](anthony-fauci.md) | Supervisore grants NIAID |

---

## Timeline

| Anno | Evento |
|------|--------|
| **1954** | Nascita, New Jersey |
| **1973** | NC State, borsa nuoto, campione ACC |
| **1977** | BSc Zoology |
| **1983** | PhD Microbiology |
| **1986** | Joins UNC Chapel Hill |
| **1990s** | Sviluppa genetica inversa per coronavirus |
| **2014** | Inizio collaborazione EcoHealth/WIV via NIH grant |
| **2015** | Paper Nature Medicine virus chimerico con Shi Zhengli |
| **2016-17** | Scoperta remdesivir come antivirale pan-coronavirus |
| **2017** | Moratorium gain-of-function (in parte per suo lavoro) |
| **2018** | Project DEFUSE proposto a DARPA (respinto) |
| **2018-19** | Collaborazione NIH/VRC per vaccino mRNA anti-MERS |
| **2020** | Riceve SARS-CoV-2, contribuisce a vaccino Moderna |
| **2020** | FDA approva remdesivir (maggio) |
| **2021** | O. Max Gardner Award, National Academy of Sciences |
| **2022** | READDI-AViDD Center, $65M da NIAID |
| **2022** | Elected, American Academy of Arts and Sciences |
| **2024** | Deposto da House Select Committee (aprile) |
| **2024** | Ex CDC Dir. Redfield lo chiama "scientific mastermind" (novembre) |
| **2025** | NC State Legislature richiede documenti (giugno) |
| **2025** | DNI Gabbard annuncia nuova indagine origini COVID |
| **2025** | Documenti ODNI/CIA su briefings Baric rilasciati da Sen. Rand Paul (ottobre) |
| **2026** | NC Court of Appeals conferma diritto UNC a trattenere documenti (gennaio) |

---

## Domande Aperte

- [ ] Natura completa della collaborazione con WIV
- [ ] Tutti i virus chimerici creati nel Baric Lab
- [ ] Contenuto completo emails con Daszak su standard BSL-2 Cina
- [ ] Futuro della ricerca gain-of-function negli USA
- [ ] Esito indagine NC State Legislature

---

## Fonti

### Istituzioni
- [UNC Gillings - Ralph S. Baric Profile](https://sph.unc.edu/adv_profile/ralph-s-baric-phd/)
- [National Academy of Sciences - Baric](https://www.nasonline.org/directory-entry/ralph-s-baric-lhxzsj/)
- [UNC System - O. Max Gardner Award](https://www.northcarolina.edu/news/ralph-baric-receives-o-max-gardner-award-for-coronavirus-research/)

### Testimonianza Congressuale
- [House Oversight - Baric Transcript (April 2024)](https://oversight.house.gov/wp-content/uploads/2024/04/Baric-TI-Transcript.pdf)
- [House Select Subcommittee - EcoHealth Report](https://oversight.house.gov/release/new-select-subcommittee-report-recommends-ecohealth-alliance-president-debarred-and-criminally-investigated-exposes-failures-in-nih-grant-procedures/)

### Wikipedia
- [Ralph S. Baric - Wikipedia](https://en.wikipedia.org/wiki/Ralph_S._Baric)

### Inchieste Giornalistiche
- [MIT Technology Review - Gain of Function Interview (July 2021)](https://www.technologyreview.com/2021/07/26/1030043/gain-of-function-research-coronavirus-ralph-baric-vaccines/)
- [MIT Technology Review - Risky Bat Virus Engineering (June 2021)](https://www.technologyreview.com/2021/06/29/1027290/gain-of-function-risky-bat-virus-engineering-links-america-to-wuhan/)
- [The Assembly NC - UNC Lab Faces Threats (2025)](https://www.theassemblync.com/education/higher-education/unc-chapel-hill-lab-baric-five-years-covid-19/)
- [TIME - The U.S. Scientist At the Heart of COVID Lab Leak Conspiracies](https://time.com/6290193/covid-lab-leak-ralph-baric/)
- [Carolina Journal - NC Investigation (June 2025)](https://www.carolinajournal.com/gov-ops-requests-records-about-unc-chapel-hill-coronavirus-researcher-baric/)

### Paper 2015
- [Nature Medicine - Original Paper](https://www.nature.com/articles/nm.3985)
- [FactCheck - Gain of Function Disagreement](https://www.factcheck.org/2021/05/the-wuhan-lab-and-the-gain-of-function-disagreement/)

### READDI / Drug Development
- [READDI-AViDD $65M Grant](https://readdi.org/stories/readdi-receives-65m-grant-from-nih-to-establish-an-antiviral-drug-discovery-avidd-center/)
- [UNC - Remdesivir Effectiveness](https://sph.unc.edu/sph-news/remdesivir-developed-at-unc-chapel-hill-proves-effective-against-covid-19-in-niaid-human-clinical-trials/)

### Brevetto
- [US Patent 7,279,327 - Recombinant Coronavirus](https://patents.google.com/patent/US7279327B2/)

### Intelligence / Origini
- [Daily Caller - ODNI/CIA Documents (Nov 2025)](https://dailycaller.com/2025/11/11/odni-cia-ralph-baric-wuhan-covid-pandemic/)
- [Carolina Journal - Redfield Claims (Nov 2024)](https://www.carolinajournal.com/former-cdc-director-claims-that-covid-19-emanated-from-unc-chapel-hill/)
- [Daily Tar Heel - Public Records Lawsuit (2025)](https://www.dailytarheel.com/article/2025/06/university-covid-origins-public-records)

---

*Ultimo aggiornamento: Febbraio 2026*
